Nephros, Inc. - Current Ratio

The Current Ratio as of August 2026 (TTM) for Nephros, Inc. (NEPH) is 4.55

According to Nephros, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.55. This represents a change of -0.83% compared to the average of 4.59 of the last 4 quarters.

Nephros, Inc. (NEPH) Historical Current Ratio (quarterly & annually)

How has NEPH Current Ratio performed in the past?

The mean historical Current Ratio of Nephros, Inc. over the last ten years is 4.63. The current 4.55 Current Ratio has changed 9.73% with respect to the historical average. Over the past ten years (40 quarters), NEPH's Current Ratio was at its highest in in the December 2020 quarter at 11.44. The Current Ratio was at its lowest in in the September 2017 quarter at 1.14.

Nephros, Inc. (NEPH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Nephros, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nephros, Inc. (NEPH) Average Current Ratio

How has NEPH Current Ratio performed in the past?

The current Current Ratio of Nephros, Inc. (NEPH) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nephros, Inc. (NEPH) Current Ratio vs. Peers

How is NEPH’s Current Ratio compared to its peers?

Nephros, Inc.’s Current Ratio is greater than Daxor Corporation (0), greater than HeartBeam, Inc. (0.74), greater than OneMedNet Corporation (0.27), less than ImmuCell Corporation (4.82), greater than OS Therapies Incorporated (0.05), greater than Jin Medical International Ltd. (1.86), greater than Outlook Therapeutics, Inc. (0.54), greater than NRx Pharmaceuticals, Inc. (0.29), less than Spruce Biosciences, Inc. (4.67), greater than Werewolf Therapeutics, Inc. (2.91),

Build a custom stock screener for Nephros, Inc. (NEPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nephros, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nephros, Inc. (NEPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nephros, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.